Competitive ConcernsSentiment on ISRG shares shifted negative heading into the 3Q:25 print on potential for competition from Restore Robotics, shifting US capital spend outlook, and some degree of US saturation.
Reimbursement ChallengesESD reimbursement does not align well with the desired payback rate for robotic surgeries.
US-China Trade DisputeTariffs, capital environment, and competition remain key concerns that could influence capital and EPS outlooks as the US/China trade dispute continues.